Initial and steady-state effects of diphenhydramine and loratadine on sedation, cognition, mood, and psychomotor performance

Archives of Internal Medicine

Volumn 157, Issue 20, 1997, Pages 2350-2356

  Kay, Gary G ^a,e   Berman, Brian ^b   Mockoviak, Sandra H ^c   Morris, Christine Eberle ^a   Reeves, Dennis ^d   Starbuck, Victoria ^a   Sukenih, Elizabeth ^b   Harris, Alan G ^c   Carson, Polly A ^f   Blackburn, Karen ^f   Najmi, Monica ^f   Gonzalez, Stefani ^f   Anchundia, Maria M ^f   Moreno, Jose ^f  

^a GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c MERCK RESEARCH LABORATORIES   (United States)

^d Natl Cognitive Recovery Foundation   (United States)

^e GEORGETOWN UNIVERSITY   (United States)

^f NONE

Author keywords

[No Author keywords available]

Indexed keywords

DIPHENHYDRAMINE; LORATADINE; PLACEBO;

ADULT; ALERTNESS; ARTICLE; ATTENTION; COGNITIVE DEFECT; CONTROLLED STUDY; DRUG EFFECT; FATIGUE; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; MOOD; MOTIVATION; NORMAL HUMAN; PRIORITY JOURNAL; PSYCHOMOTOR PERFORMANCE; SEDATION; SOMNOLENCE; WORKING MEMORY;

EID: 14444276731     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.157.20.2350     Document Type: Article

References (26)

1. Luscombe DK, Nicholls PJ, Parish PA. Comparison of the effects of azatadine maleate and terfenadine on human performance. Pharmatherapeutics. 1980;3:370-375.
2. 1-histamine receptor antagonists, astemizole and terfenadine. Br J Clin Pharmacol. 1982;13:199-202.
3. 1-antagonist mequitazine: studies on performance and visual function. Eur J Clin Pharmacol. 1983;25:563-566.
4. Gengo F, Gabos C, Miller JK. The pharmacodynamics of diphenhydramine-induced drowsiness and changes in mental performance. Clin Pharmacol Ther. 1989;45:15-21.
5. Moskowitz H. Attention tasks as skills performance measures of drug effects. Br J Clin Psychopharmacol. 1984;18(suppl):51S-61S.
6. Del Carpio J, Kabbash L, Turenne Y, et al. Efficacy and safety of loratadine (10 mg once daily), terfenadine (60 mg twice daily), and placebo in the treatment of seasonal allergic rhinitis. J Allergy Clin Immunol. 1989;84:741-746.
7. Horak F, Bruttmann G, Pedrali P, et al. A multicentric study of loratadine, terfenadine and placebo in patients with seasonal allergic rhinitis. Arzneimittelforsch. 1988;38:124-188.
8. Dockhorn RJ, Bergner A, Connell JT, et al. Safety and efficacy of loratadine (Sch-27851): a new non-sedating antihistamine in seasonal allergic rhinitis. Ann Allergy. 1987;58:407-411.
9. Pechadre JC, Beudin P, Eschalier A, Trolese JF, Rihoux J-P. A comparison of central and peripheral effects of cetirizine and loratadine. J Int Med Res. 1991;19:289-295.
10. Ramaekers JG, Uiterwijk MMC, O'Hanlon JF. Effects of loratadine and cetirizine on actual driving and psychometric test performance, and EEG during driving. Eur J Clin Pharmacol. 1992;42:363-369.
11. Betts T, Wild J, Ross R, Kenwood C, Thirtle-Watts R. A double-blind, single-dose study of the effects of loratadine on driving skills in normal volunteers. Read before the XIII International Congress of Allergy and Clinical Immunology; June, 1988; Montreux, Switzerland.
12. 1-antagonist, loratadine. Eur J Clin Pharmacol. 1987;30:419-421.
13. Neves-Pinto RM, Moreira Lima G, Mota Teixeira R. A double-blind study of the effects of loratadine versus placebo on the performance of pilots. Am J Rhinol. 1992;6:23-27.
14. Kay GG. CogScreen-Aeromedical Edition: Professional Manual. Odessa, Fla: Psychological Assessment Resources Inc; 1995.
15. Samet M, Geiselman RE, Zajaczkowski F, Marshall-Mies J. Complex Cognitive Assessment Battery (CCAB): Test Descriptions. Alexandria, Va: US Army Research Institute; 1986.
16. Reeves DL, Winter KP, LaCour S, et al. Automated Neuropsychological Assessment Metrics Documentation, Volume I: Test Administration Guide. Silver Springs, Md: Office of Military Performance Assessment Technology; 1992.
17. Kane RL, Kay GG. Computerized assessment in neuropsychology: a review of tests and test batteries. Neuropsychol Rev. 1992;3:1-117.
18. Gengo FM, Gabos C, Mechtler L. Quantitative effects of cetirizine and diphenhydramine on mental performance measured using an automobile driving simulator. Ann Allergy. 1990;64:520-526.
19. Burns H, Moskowitz H. Effects of diphenhydramine and alcohol on skills performance. Eur J Clin Pharmacol. 1980;17:259-266.
20. Cohen AF, Posner J, Ashby L, Smith R, Peck AW. A comparison of methods for assessing sedative effects of diphenhydramine on skills related to driving a car. Eur J Clin Pharmacol. 1984;27:477-482.
21. Linnotla M. Effects of antihistamines, chlormezanone and alcohol on psychomotor skills related to driving. Eur J Clin Pharmacol. 1973;5:247-254.
22. Hoddes E, Zarcone V, Smythe H, Phillips R, Dement W. Quantification of sleepiness: a new approach. Psychophysiology. 1973;10:429-436.
23. Norusis MJ. SPSS for Windows Advanced Statistics, Version 6.0. Chicago, III: SPSS Inc; 1993.
24. SAS/STAT User's Guide, Version 6, Volumes 1 and 2. 4th ed. Cary, NC: SAS Institute Inc; 1989.
25. Herberg K-W. Studie zur Fahrtuchtigkeit nach Einnahme von Loratadin. Munch Med Wochenschr. 1990;130:463-467.
26. Heaton RK, Grant I, Matthews CG. Comprehensive Norms for an Expanded Halstead-Reitan Battery: Demographic Corrections, Research Findings, and Clinical Applications. Odessa, Fla: Psychological Assessment Resources; 1991.